Goldman Sachs Adds Merck (MRK) To Its Conviction Buy List

Goldman Sachs is removing its Not Rated designation on Merck (NYSE: MRK), setting a Buy rating and adding the stock to its Conviction Buy List. The firm said the stocks discount to the market sets shares up for substantial outperformance over the next 12 months on the back of the potential for cost-driven earnings acceleration. Revenue upside provides further upside. The firm set a $38 price target on MRK.

Real-Time Market Moving News Two-Weeks FREE http://www.streetinsider.com/premium_content.php

You May Also Be Interested In

• Goldman Sachs Keeps Top Rating on Ralph Lauren (RL) After Q4 Results, Says Buy Pullback
• Deutsche Bank Cuts Price Target and EPS Estimates on J. C. Penney (JCP); There's Only Two Ways This Can Go
• UBS Maintains a 'Buy' on Ralph Lauren (RL); Taking A More Conservative Approach

Create E-mail Alert Related Categories

Analyst Comments, New Coverage, Trader Talk

Related Entities

Goldman Sachs Conviction Buy List, UBS

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?

Follow StreetInsider.com On Twitter